The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

At’kova E.L.

Scientific Research Institute of Eye Diseases, Moscow, Russia

Reyn D.A.

Research Institute of Eye Diseases, 11 A, B Rossolimo St., Moscow, 119021, Russian Federation

Yartsev V.D.

Scientific Research Institute of Eye Diseases, Moscow, Russia

Subbot A.M.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Influence of TGF-β cytokine and a number of other biochemical factors on regenerative process

Authors:

At’kova E.L., Reyn D.A., Yartsev V.D., Subbot A.M.

More about the authors

Journal: Russian Annals of Ophthalmology. 2017;133(4): 89‑96

Read: 2756 times


To cite this article:

At’kova EL, Reyn DA, Yartsev VD, Subbot AM. Influence of TGF-β cytokine and a number of other biochemical factors on regenerative process. Russian Annals of Ophthalmology. 2017;133(4):89‑96. (In Russ.)
https://doi.org/10.17116/oftalma2017133489-96

Recommended articles:
Biomarkers of athe­rothrombotic and cardioembolic subtypes of acute ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):20-26
Inflammatory aging. Part 2. Are there diagnostic biomarkers available. Russian Journal of Preventive Medi­cine. 2025;(1):89-95
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Pathogenesis of fibrosis deve­lopment in ovarian endo­metriosis. Russian Journal of Archive of Pathology. 2025;(2):73-78
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12

References:

  1. Beloglazov V, At’kova E, Abdurakhmanov G, Krakho-vetskiĭ N. Prevention of ostial obstruction after microendoscopic endonasal dacryocystorhinostomy. Vestnik oftal’mologii. 2013;129(2):19-22. (In Russ.)
  2. Sharma H, Sharma A, Sharma R. Modified external dacryocystorhinostomy in primary acquired nasolacrimal duct obstruction. J Clin Diagn Res. 2015;9(10):1-5. https://doi.org/10.7860/jcdr/2015/15940.6624
  3. Leong S, Karkos P, Burgess P, Halliwell M, Hampal S. A comparison of outcomes between nonlaser endoscopic endonasal and external dacryocystorhinostomy: single-center experience and a review of British trends. Am J Otolaryngol. 2010;31(1):32-37. https://doi.org/10.1016/j.amjoto.2008.09.012
  4. At’kova E, Fedorov A, Beloglazov V, Abdurakhmanov G, Reznikova L. The value of cytologic investigation for postoperative assessment in patients with nasolacrimal obstruction. Vestnik oftal’mologii. 2010;126(6):26-29. (In Russ.)
  5. Beule A. Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010;9:Doс07. https://doi.org/10.3205/cto000071
  6. Heindl L, Junemann A, Holbach L. A Clinicopathologic Study of Nasal Mucosa in 350 Patients with External Dacryocystorhinostomy. Orbit. 2009;28:7-11. https://doi.org/10.1080/01676830802414806
  7. Serov V, Shekhter A. Soedinitel’naya tkan’. M.: Meditsina; 1981: 312. (In Russ.)
  8. Gabbiani G, Ryan G, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia. 1971;27:549-550. https://doi.org/10.1007/bf02147594
  9. Hinz B, Gabbiani G, Seemayer T, Schürch W. Myofibroblast. In: Mills SE, eds. Histology for Pathologists, Fouth Edition. Philadelphia, U.S.A: Lippincott-Williams & Wilkins Pub; 2012:131-177.
  10. Wilson SE, Chaurasia SS, Medeiros FW. Apoptosis in the initiation, modulation and termination of the corneal wound healing response. Exp Eye Res. 2007;85(3):305-311. https://doi.org/10.1016/j.exer.2007.06.009
  11. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci. 2001;114(24): 4359-4369.
  12. Kumar V, Ali MJ, Ramachandran C. Effect of mitomycin-C on contraction and migration of human nasal mucosa fibroblasts: implications in dacryocystorhinostomy. Br J Ophthalmol. 2015;99(9):1295-1300. https://doi.org/10.1136/bjophthalmol-2014-306516
  13. Maier P, Broszinski A, Heizmann U, Böhringer D, Reinhardau T. Active transforming growth factor-beta2 is increased in the aqueous humor of keratoconus patients. Mol Vis. 2007;13:1198-1202.
  14. Engler C, Chakravarti S, Doyle J, Eberhart CG, Meng H, Stark WJ, Kelliher C, Jun AS. Transforming growth factor-β signaling pathway activation in Keratoconus. Am J Ophthalmol. 2011;151(5):752-759.e2. https://doi.org/10.1016/j.ajo.2010.11.008
  15. Inatani M, Tanihara H, Katsuta H, Honjo M, Kido N, Honda Y. Transforming growth factor-beta 2 levels in aqueous humor of glaucomatous eyes. Graefes Arch Clin Exp Ophthalmol. 2001;239(2):109-113. https://doi.org/10.1007/s004170000241
  16. Picht G, Welge-Luessen U, Grehn F, Lutjen-Drecoll E. Transforming growth factor beta 2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb development. Graefes Arch Clin Exp Ophthalmol. 2001;239(3):199-207. https://doi.org/10.1007/s004170000252
  17. Huang T, Schor SL, Hinck AP. Biological activity differences between TGF-beta1 and TGF-beta3 correlate with differences in the rigidity and arrangement of their component monomers. Biochemistry. 2014; 53(36): 5737-5749. https://doi.org/10.1021/bi500647d
  18. Karamichos D, Hutcheon AE, Zieske JD. Reversal of fibrosis by TGF-beta3 in a 3D in vitro model. Exp Eye Res. 2014;124:31-36. https://doi.org/10.1016/j.exer.2014.04.020
  19. Bettahi I, Sun H, Gao N, Wang F, Mi X, Chen W, Liu Z, Yu FS. Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGFbeta3 expression contributes to the delay of epithelial wound healing in diabetic corneas. Diabetes. 2014;63(2):715-727. https://doi.org/10.2337/db13-1260
  20. Wang F, Gao N, Yin J, Yu FS. Reduced innervation and delayed reinnervation after epithelial wounding in type 2 diabetic Goto-Kakizaki rats. Am J Pathol. 2012;181(6):2058-2066. https://doi.org/10.1016/j.ajpath.2012.08.029
  21. Xu K, Yu FS. Impaired epithelial wound healing and EGFR signaling pathways in the corneas of diabetic rats. Invest Ophthalmol Vis Sci. 2011;52(6):3301-3308. https://doi.org/10.1167/iovs.10-5670
  22. Robertson IB, Rifkin DB. Unchaining the beast; insights from structural and evolutionary studies on TGFbeta secretion, sequestration, and activation. Cytokine Growth Factor Rev. 2013;24(4):355-372. https://doi.org/10.1016/j.cytogfr.2013.06.003
  23. Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH, Pellicoro A, Raschperger E, Betsholtz C, Ruminski PG, Griggs DW, Prinsen MJ, Maher JJ, Iredale JP, Lacy-Hulbert A, Adams RH, Sheppard D. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med. 2013;19(12):1617-1624. https://doi.org/10.1038/nm.3282
  24. Klingberg F, Chow ML, Koehler A, Boo S, Buscemi L, Quinn TM, Costell M, Alman BA, Genot E, Hinz B. Prestress in the extracellular matrix sensitizes latent TGFbeta1 for activation. J Cell Biol. 2014;207(2):283-297. https://doi.org/10.1083/jcb.201402006
  25. Wong TT, Mead AL, Khaw PT. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2005;46(6):2018-2022. https://doi.org/10.1167/iovs.04-0820
  26. Iyer RP, Patterson NL, Fields GB, Lindsey ML. The history of matrix metalloproteinases: milestones, myths, and misperceptions. Am J Physiol Heart Circ Physiol. 2012;303(8):919-930. https://doi.org/10.1152/ajpheart.00577.2012
  27. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14(2):163-176.
  28. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol. 2002;157(3):493-507. https://doi.org/10.1083/jcb.200109100
  29. Daniels JT, Cambrey AD, Occleston NL, Garrett Q, Tarnuzzer RW, Schultz GS, Khaw PT. Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci. 2003;44(3):1104-1110. https://doi.org/10.1167/iovs.02-0412
  30. Lanza NL, Valenzuela F, Perez VL, Galor A. The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eyе. Ocul Surf. 2016;14(2):189-195. https://doi.org/10.1016/j.jtos.2015.10.004
  31. Raugi GJ, Olerud JE, Gown AM. Thrombospondin in early human wound tissue. J Invest Dermatol. 1987;89(6):551-554. https://doi.org/10.1111/1523-1747.ep12461198
  32. Murphy-Ullrich JE, Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev. 2000;11(1-2):59-69. https://doi.org/10.1016/s1359-6101(99)00029-5
  33. Matsuba M, Hutcheon AE, Zieske JD. Localization of thrombospondin-1 and myofibroblasts during corneal wound repair. Exp Eye Res. 2011;93(4): 534-540. https://doi.org/10.1016/j.exer.2011.06.018
  34. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 1988;106(5):1659-1665. https://doi.org/10.1083/jcb.106.5.1659
  35. Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-beta 1. Mol. Endocrinol. 1996;10(9):1077-1083. https://doi.org/10.1210/me.10.9.1077
  36. He J, Bazan HE. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. Invest Ophthalmol Vis Sci. 2006;47(3):883-891. https://doi.org/10.1167/iovs.05-0581
  37. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10(1):45-65.
  38. Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003;66(8):1403-1408. https://doi.org/10.1016/s0006-2952(03)00490-8
  39. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature. 1997;388:548-554.
  40. Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal. 2010;3(105):cm1. https://doi.org/10.1126/scisignal.3105cm1
  41. Barbosa FL, Chaurasia SS, Kaur H, de Medeiros FW, Agrawal V, Wilson SE. Stromal interleukin-1 expression in the cornea after haze-associated injury. Exp Eye Res. 2010;91(3):456-461. https://doi.org/10.1016/j.exer.2010.06.023
  42. Jun JI, Lau LF. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov. 2011;10:945-963. https://doi.org/10.1038/nrd3599
  43. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N, Lin A, Yeowell D. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis Tissue Repair. 2011;4(1):4. https://doi.org/10.1186/1755-1536-4-4
  44. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010;106(11):1675-1680. https://doi.org/10.1161/circresaha.110.217737
  45. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601. https://doi.org/10.1111/j.1524-475x.2008.00410.x
  46. Park HY, Kim JH, Park CK. VEGF induces TGF-beta1 expression and myofibroblast transformation after glaucoma surgery. Am J Pathol. 2013;182(6):2147-2154. https://doi.org/10.1016/j.ajpath.2013.02.009
  47. Noh SM, Abdul Kadir SH, Crowston JG, Subrayan V, Vasudevan S. Effects of ranibizumab on TGF-β1 and TGF-β2 production by human Tenon’s fibroblasts: An in vitro study. Mol Vis. 2015;21:1191-200.
  48. Heldin CH. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun Signal. 2013;11(1):97. https://doi.org/10.1186/1478-811x-11-97
  49. Kaur H, Chaurasia SS, de Medeiros FW, Agrawal V, Salomao MQ, Singh N, Ambati BK, Wilson SE. Corneal stroma PDGF blockade and myofibroblast development. Exp Eye Res. 2009;88(5):960-965. https://doi.org/10.1016/j.exer.2008.12.006
  50. Singh V, Santhiago MR, Barbosa FL, Agrawal V, Singh N, Ambati BK, Wilson SE. Effect of TGFbeta and PDGF-B blockade on corneal myofibroblast development in mice. Exp Eye Res. 2011;93(6):810-817. https://doi.org/10.1016/j.exer.2011.09.012
  51. Webber J, Jenkins RH, Meran S, Phillips A, Steadman R. Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan. Am J Pathol. 2009;175(1):148-160. https://doi.org/10.2353/ajpath.2009.080837
  52. Guo N, Li X, Mann MM, Funderburgh ML, Du Y, Funderburgh JL. Hyaluronan synthesis mediates the fibrotic response of keratocytes to transforming growth factor beta. J Biol Chem. 2010;285(42):32012-32019. https://doi.org/10.1074/jbc.m110.127183
  53. Bornstein P, Sage EH. Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol. 2002;14(5):608-616. https://doi.org/10.1016/s0955-0674(02)00361-7
  54. Seet LF, Su R, Barathi VA, Lee WS, Poh R, Heng YM, Manser E, Vithana EN, Aung T, Weaver M, Sage EH, Wong TT. SPARC deficiency results in improved surgical survival in a novel mouse model of glaucoma filtration surgery. PLoS One. 2010;5(2):9415. https://doi.org/10.1371/journal.pone.0009415
  55. Cushing MC, Mariner PD, Liao JT, Sims EA, Anseth KS. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. Faseb J. 2008;22(6):1769-1777. https://doi.org/10.1096/fj.07-087627
  56. Talele NP, Fradette J, Davies JE, Kapus A, Hinz B. Expression of α-Smooth Muscle Actin Determines the Fate of Mesenchymal Stromal Cells. Stem Cell Reports. 2015;4(6):1016-1030. https://doi.org/10.1016/j.stemcr.2015.05.004
  57. Sobral LM, Montan PF, Martelli-Junior H, Graner E, Coletta RD. Opposite effects of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival cell cultures. J Clin Periodontol. 2007;34(5): 397-406. https://doi.org/10.1111/j.1600-051x.2007.01063.x
  58. Hori K, Matsuda A, Ebihara N, Imai K, Mori K, Funaki T, Watanabe Y, Nakatani S, Okada K, Matsuo O, Murakami A. Involvement of plasminogen activator inhibitor-1 in the pathogenesis of atopic cataracts. Invest Ophthalmol Vis Sci. 2012;53(4):1846-1851. https://doi.org/10.1167/iovs.11-8380
  59. Xing D, Bonanno JA. Hypoxia reduces TGFbeta1-induced corneal keratocyte myofibroblast transformation. Mol Vis. 2009;15:1827-1834.
  60. Boehm N, Riechardt AI, Wiegand M, Pfeiffer N, Grus FH. Proinflammatory cytokine profiling of tears from dry eye patients by means of antibody microarrays. Invest Ophthalmol Vis Sci. 2011;52(10):7725-7730. https://doi.org/10.1167/iovs.11-7266
  61. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42:2283-2292.
  62. Poyraz C, Irkec M, Mocan MC. Elevated tear interleukin-6 and interleukin-8 levels associated with silicone hydrogel and conventional hydrogel contact lens wear. Eye Cont Lens. 2012;38(3):146-149. https://doi.org/10.1097/icl.0b013e3182482910
  63. Lopilly Park HY, Kim JH, Lee KM, Park CK. Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and cornea. Exp Eye Res. 2012;94(1):13-21. https://doi.org/10.1016/j.exer.2011.10.017
  64. Kim HJ, Kim PK, Yoo HS, Kim CW. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Clin Biochem. 2012;45(1-2):60-67. https://doi.org/10.1016/j.clinbiochem.2011.10.006
  65. Lee JK, Kim TH. Changes in cytokines in tears after endoscopic endonasal dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction. Eye. 2014;28(5):600-607. https://doi.org/10.1038/eye.2014.33
  66. Smirnov G, Pirinen R, Tuomilehto H, Seppa J, Terasvirta M, Uusitalo H, Nuutinen J, Kaarniranta K. Strong expression of HSP47 in metaplastic nasal mucosa may predict a poor outcome after primary endoscopic dacryocystorhinostomy: a prospective study. Acta Ophthalmol. 2011;89(2):132-136. https://doi.org/10.1111/j.1755-3768.2009.01654.x
  67. Penttilä E, Hyttinen J, Hytti M, Kauppinen A, Smirnov G, Tuomilehto H, Seppä J, Nuutinen J, Kaarniranta K. Upregulation of inflammatory genes in the nasal mucosa of patients undergoing endonasal dacryocystorhinostomy. Clinical Ophthalmology. 2014;8:799-805. https://doi.org/10.2147/opth.s50195

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.